Dramatically changed immune‐related molecules as early diagnostic biomarkers of non‐small cell lung cancer-Reference-Cited by-同舟云学术

Dramatically changed immune‐related molecules as early diagnostic biomarkers of non‐small cell lung cancer

Published:2019-09-20 Issue:4 Volume:287 Page:783-799
ISSN:1742-464X
Container-title:The FEBS Journal
language:en
Short-container-title:FEBS J

Author:

Ye Xiangdong¹,Zhang Ni²,Jin Yanxia¹,Xu Bo¹,Guo Chanyuan¹,Wang Xueqing¹,Su Yanting¹,Yang Qing¹,Song Jiaqi¹,Yu Wenhui¹,Cheng Pengfei³,Cheng Liming⁴,Gong Yongsheng⁵,Fu Xiangning²,Sun Hui¹⁶^ORCID

Affiliation:

1. Hubei Key Laboratory of Cell Homeostasis College of Life Sciences Wuhan University China

2. Department of Thoracic Surgery Tongji Medical College Tongji Hospital Huazhong University of Science and Technology Wuhan China

3. Department of Laboratory Medicine Wuhan University Hospital Wuhan University China

4. Department of Laboratory Medicine Tongji Medical College Tongji Hospital Huazhong University of Science and Technology Wuhan China

5. Department of Thoracic‐Cardiovascular Surgery Suzhou Municipal Hospital Nanjing Medical University Suzhou China

6. Hubei Province Key Laboratory of Allergy and Immunology College of Life Sciences Wuhan University China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cell Biology,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/febs.15051

Reference50 articles.

1. Global cancer statistics, 2012

2. Diagnosis of Lung Cancer in Small Biopsies and Cytology: Implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society Classification

3. Lung cancer and the future of pathology;Cagle PT;Arch Pathol Lab Med,2011

4. The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours

5. Lung Cancer Biomarkers: Present Status and Future Developments

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine-learning and scRNA-Seq-based diagnostic and prognostic models illustrating survival and therapy response of lung adenocarcinoma;Genes & Immunity;2024-07-29

2. Sex differences in the tumor promoting effects of tobacco smoke in a cRaf transgenic lung cancer disease model;Archives of Toxicology;2024-01-21

3. The effectiveness of blood-activating and stasis-transforming traditional Chinese medicines (BAST) in lung cancer progression-a comprehensive review;Journal of Ethnopharmacology;2023-10

4. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis;Scientific Reports;2023-09-21

5. A diagnostic biomarker of acid glycoprotein 1 for distinguishing malignant from benign pulmonary lesions;The International Journal of Biological Markers;2023-09-01